NZMA Home

Table of contents
Current issue
Search journal
Archived issues
NZMJ Obituaries 1887-2008
Classifieds
Hotline (free ads)
How to subscribe
How to contribute
How to advertise
Contact Us
Copyright
Other journals
The New Zealand Medical Journal

 Journal of the New Zealand Medical Association, 08-October-2004, Vol 117 No 1203

Performance indicators: primary health, secondary care, and diabetes
Rigorously measured outcomes are scarce in local healthcare systems, especially for cost-effectiveness in prevention of common disorders.
A seminal paper by Crampton and colleagues (published in the 2 April 2004 issue of the NZMJ)1 is valuable—although it went largely unnoticed. It thoroughly canvassed important criteria for primary care indicators. Diabetes is used as an example. Diabetes also crosses into a secondary care prevention indicator of high-cost ‘open-ended’ hospital admissions being an objective international indicator.2
There are other compelling reasons why diabetes is New Zealand’s best performance indicator. For example, in USA a well as New Zealand, diabetes is ranked first because of its killing propensities.3 In addition, in a New Zealand survey, 210,000 diabetes patients and their families are involved with 14% of the overall hospital costs.
Prevention and better quality care could reduce these costly hospitalisations5,6 and half of the cases of kidney failure and dialysis could be prevented,4,5 by better use of diabetes performance indicators. The same applies for coronary disease, blindness, and amputations if there was more investment in moving upstream.3,7
Insulin resistance and pre-diabetes may be present for 20 years before a diabetes diagnosis is made—often itself delayed 12 years or more. Upstream screening of blood sugars thus becomes a key indicator in a common disorder.8
Eight percent of adults had undiagnosed diabetes in the Ausdiab Study; and unknown rates of diabetes will prove to be an unsustainable cost in New Zealand.9 Raised blood glucose is also a key indicator for morbidity, and all cause mortality as well as the earliest predictor of preventable cardiovascular diseases.10
New Zealand’s yearly ‘get checked’ programme (3 years’ stored results) yields a unique continuing data set. Those persons with diabetes want these 12 digitally transmissible items used.
Health systems should maintain wellness in the clash between financially imposed environments and our ‘hunter-gatherer’ genes. Diabetes can be used (via these health systems) as an ideal performance indicator of accomplishment spanning primary, secondary, and tertiary preventions—and to monitor social community and educational inputs to health preservation.
Crampton and colleagues clearly listed four excellent key performance indicator uses. A fifth would be the educative function of encrypted peer-reviewed rankings from the ‘get checked’ results thus allowing improvement and changes to practice.
Indeed, with 40 patients per doctor in New Zealand, diabetes is an invaluable and unique performance indicator.
Don W Beaven
Patron
Murray Dear
President
Sarah Thomson
CEO
Diabetes New Zealand Inc

References:
  1. Crampton P, Perera R, Crengle S, et al. What makes a good performance indicator? Devising primary care performance indicators for New Zealand. N Z Med J. 2004;117(1191). URL: http://www.nzma.org.nz/journal/117-1191/820
  2. McKee M, Nolte E. Responding to the challenge of chronic disease ideas from Europe. Clinical Med. 2004;4:336–42.
  3. McKinlay J, Marceau L. US Public Health and the 21st Century: Diabetes Mellitus Lancet. 2000;356:757–61.
  4. Chen F, Florkowski CM, Dever M, Beaven DW. Death certification and New Zealand Health Information Service statistics for diabetes mellitus; an under recognized health problem. Diabetes Res Clin Pract. 2004;63:113–8.
  5. Zimmet P. The burden of Type 2 diabetes: are we doing enough? Diabetes Metab. 2003;29:659–18.
  6. Editorial: Target people with pre diabetes. BMJ. 2002;325:403–4.
  7. Davies MJ. The prevention of diabetes mellitus. Clinical Medicine. 2003;5:470–4.
  8. Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle aged non diabetic man. Diabetes Care. 1998;21:360–7.
  9. Pricewaterhouse Coopers Type 2 diabetes: Managing far better health outcomes. Commissioned by Diabetes New Zealand Inc. April 2001; p127.
  10. Koroce, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with Type 2 diabetes. Diabetes Care. 2004;27:17–20.


     
Current issue | Search journal | Archived issues | Classifieds | Hotline (free ads)
Subscribe | Contribute | Advertise | Contact Us | Copyright | Other Journals